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Abstract 
The DNA mutator enzyme, activation–induced cytidine deaminase (AID) is expressed in mature 
B lymphocytes, and initiates the secondary antibody diversification events of somatic 
hypermutation (SHM) and class switch recombination (CSR) which mutates cytidine to uridine at 
Immunoglobulin loci. To date, the expression hosts for purification of AID/APOBECs include 
bacteria, insect or mammalian cell lines. Here we established and optimized a novel yeast–based 
expression/secretion system to express AID. This is compatible with different purification tags 
including GST and His positioned at either N- or C-termini or non-tag. This method also can be 
adapted for protein secretion into the media, allowing for a simpler purification method of 
concentrating and collecting the protein from the media, rather than current conventional 
purification methods. As proof of principle, we provide the first report of expression of 
functionally active untagged AID as well as GST-AID and AID-His which can address several 
important unanswered questions remaining in the field. 
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Introduction 
 
1.1 The activation- induced cytidine deaminase (AID) enzyme is required for antibody 
diversification. 
There are a total of eleven family members AID/APOBEC enzymes including APOBEC1, 
activation-induced deaminase (AID), APOBEC2, APOBEC3s (A3A, A3B, A3C, A3D, A3F, A3G, 
and A3H), and APOBEC4 (Table 1).  AID /APOBECs are DNA-editing cytidine deaminases with 
the activity of deaminating deoxycytidine (dC) in single stranded DNA (ssDNA), RNA and 
supercoiled transcribed DNA, thus converting it into deoxyuridine (dU) (Conticello et al., 2008).  
AID acts in the antigen-driven antibody diversification process by mutating genomes of activated 
lymphocytes while the A3 branch relatives mutate genomes of retroviruses, thus mediating 
adaptive/innate anti-viral defense (Honjo et al., 2004; Honjo et al,. 2002; Harris et al,. 2003; 
Conticello et al,. 2005 and Harris et al,. 2008). Human AID is a small enzyme of 198 amino acids 
that is normally expressed only in B lymphocytes that have been activated by their specific antigen 
and migrated to lymph node germinal centers (GC). In vitro, purified AID preferentially mutates 
dC within the trinucleotide WRC (W=A/T, R=A/G) motif, and this is the same sequence specificity 
that is observed when AID is expressed in bacteria or eukaryotic cells as well as the pattern found 
in B lymphocytes (Larijani et al., 2007; Rada et al., 2004; Martin et al., 2002; Honjo et al., 2008 
and Conticello et al., 2008). In activated B lymphocytes, AID targets the antibody genes, and by 
creating C:G to T:A base changes, it initiates antibody genes hypermutation (SHM) and class 
switch recombination (CSR), leading to antibody diversification (Fig. 1a) (Longerich et al., 2006; 
Muramatsu et al., 1999; Muramatsu et al., 2000; Revy et al., 2000; Martin et al., 2002; Barreto et 
al., 2005; Neuberger et al., 2005). Although AID is somewhat preferentially targeting the antibody 
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genes in activated B cells, it often targets non-Ig genes in immune cells, or is aberrantly expressed 
in non-immune cells. As a result, there are a host of AID-driven genomic lesions that lead to the 
transformation into cancer. These include AID mutation of the proto-oncogenes PIM1, MYC, 
RhoH/TTF (ARHH), and PAX5 (Pasqualucci et al., 2008), tumor suppressor and genomic stability 
genes, and AID-driven IgH/cmyc, IgH/bcl2 and IgH/bcl6 chromosomal translocations (Shen et al., 
2000 and Jankovic et al., 2009) that lead to lymphomas derived from germinal center. This 
genomic instability leads to rampant mutations and chromosomal translocations that transform 
normal cells into cancers. In epigenetics, AID may mediate so-called active demethylation by 
deamination of methylated deoxycytidines, which has the potential to alter gene expression(Fig. 
1b) (Mechtcheriakova et al., 2012; Durandy et al., 2006; Dooley et al., 2006; Revy et al., 2000). 
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Table 1. A summary of known members in human APOBEC family and their properties 
 
 
 
Enzyme Tissue expression Associated function Targets 
APOBEC1 
GI tract Unknown 
Apolipoprotein B 
mRNA 
APOBEC2 Heart and skeletal muscle 
Viral and 
retrotransposon 
restriction 
Unknown 
APOBEC3A 
Primary monocytes, 
keratinocytes 
Viral and 
retrotransposon 
restriction 
Adeno-associated 
virus, HPV, LINE-1 
APOBEC3B 
T cells, PBMC, Intestine, uterus, 
mammary gland,  keratinocytes, 
other 
Viral and 
retrotransposon 
restriction 
Retroviruses, 
retrotransposons, 
HBV 
APOBEC3C 
Many tissues 
 
Viral and 
retrotransposon 
restriction 
Retroviruses, HBV, 
retrotransposons, 
HPV 
APOBEC3D Thyroid, spleen, blood 
Viral restriction Retroviruses, 
APOBEC3F Many tissues, T cells 
Viral and 
retrotransposon 
restriction 
Retroviruses, 
retrotransposons, 
HBV, HIV 
APOBEC3G Many tissues, T cells 
Viral and 
retrotransposon 
restriction 
Retroviruses, 
retrotransposons, 
HBV, HIV, HCV 
APOBEC3H 
Poorly expressed due to 
a premature stop codon 
Viral restriction once 
expression is optimized 
Retroviruses, 
APOBEC4 Testis Unknown Unknown 
AID 
Activated B-cells, 
primordial germ cells, Breast Tissue 
Antibody maturation Immunoglobulin gene 
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AID
Constant region exonsJ segment  V segments D segment  
Oncogenes
Tumor Suppressors
Genomic stability genes 
Pluripotency genes 
Epigenetic modification
mutations
Chromosomal 
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b
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Figure 1. AID in immunity and cancer.  
(a) Somatic hypermuation (SHM) and class switch recombination (CSR) of B-cell 
immunoglobulin (Ig) genes are initiated by AID-mediated mutations. Secondary antibody 
diversification process that occurs in the germinal center of the lymph nodes is SHM. It targets antigen 
binding regions in the variable sequences of both heavy and light chains and increases their affinity to 
specific antigens by introducing point mutations in the V(D)J exon. CSR process takes place in the 
germinal centers of the lymph nodes and is driven by AID which introduces double stranded breaks in 
the switch (S) regions resulting in the removal of the constant region and joining of a new constant 
region. (b) AID, although usually tightly regulated to avoid off-target activity, has been shown to 
target nuclear DNA and cause cancer. Under pathophysiological circumstances, AID may target 
non-Ig genes, including cancer-related genes such as oncogenes, tumor suppressor genes, genomic 
stability genes, and pluripotency genes, leading to accumulation mutations and chromosomal 
translocations and epigenetics modification.  
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1.2 Current methods for studying purified AID for function and structure 
 In order to study the enzymatic activity, molecular mechanisms and structure of AID as well 
interactions with other cellular proteins, it first needs to be purified. Unfortunately, AID is 
notoriously difficult to purify, and we are currently one of only a handful of labs with the expertise 
to work with a purified AID enzyme (Larijani et al., 2012; Robbiani et al., 2009; Cocker et al., 
2016). The reason for this difficulty is two-fold: The first issue is that AID is by virtue of its activity 
and biological purpose, highly genotoxic. That is, when expressed at high levels, it can inflict 
mutations to the genome of the very host cells that it is expressed in, eventually causing cell death. 
For this reason, it can only be expressed for brief periods and at low levels, compared to other non-
toxic proteins.  
 To date, we and others have developed expression systems for AID in both prokaryotic (bacteria), 
and eukaryotic (human, mouse or insect cells) hosts. Each has its own advantages: bacterial 
systems allow for the production of ample quantities of enzyme (in the milligram range per 
purification) because bacterial cultures are easily scaled up in volume. However, only a small 
fraction of the AID molecule is active because bacteria lack the sophisticated protein production 
machinery of eukaryotic cells and most often mis-fold human proteins. We estimated from 
classical Michaelis-Menten enzymes kinetic analysis enzyme assays that in the best cases only 1 
in 1000-10000 AID molecule is folded correctly (Larijani et al., 2007), with the remainder acting 
as inert proteins, much like a non-specific protein such as Bovine Serum Albumin (BSA) in 
solution. On the other hand, eukaryotic cells produce a much higher quality of AID, but they are 
slow growing, much more prone to death due to heavy genome damage caused by AID, and time-
consuming and costly to scale up. As a result the overall yield of AID protein is typically 2-3 
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orders of magnitude lower than in bacterial systems (in the nanogram-microgram range per 
purification).   
The second issue is that AID, like some other APOBECs, has a surface that is highly positively 
charged. In fact, amongst AID/APOBECs, AID carries the highest positive charge (+14) which we 
and others have shown is due to an over-abundance of positively-charged lysine and arginine 
residues, particularly on the surface (King  et al., 2015 and 2017; Pham et al., 2016). This is in line 
with its function, which requires binding to negatively charged ssDNA in order to mutate it; 
however, it presents a challenge in purification because it results in considerable non-specific 
protein-protein interactions with other cellular proteins (King et al., 2017). One way to mitigate 
this issue has been to attach bulky purification tags, to either the N-terminal or C-terminal of AID, 
and use these tags as a bait to purify AID. Examples of these protein tags range from the 6 amino 
acid long poly histidine (His) tag to the 200 amino acid long Glutathione S transferase (GST) tag. 
We and others have successfully used both tags with their corresponding affinity binding columns 
(His-binding or GST-binding) to purify various AID/APOBEC enzymes (Bransteitter et al., 2009; 
Abdouni et al., 2013; Abdouni et al., 2017 submitted). This method has the advantage that it greatly 
facilitates purification, but the disadvantage that the resulting AID enzyme is modified, because 
the presence of a tag at their N- or C-termini can exert subtle influences on the folding of the AID 
itself. This is especially relevant for AID, since we and others have shown that even the residues 
at the ends of the N- and C-termini have critical functions in regulating the enzymatic activity, 
cellular trafficking and structural folding integrity (King  et al., 2015 and  2017; Zahn et al., 2014 
; Mondal et al., 2016).   
Another disadvantage of purification tags is that they can interfere with the natural oligomerization 
of AID. Certain tags (e.g. GST) are self-attracting thus resulting in artificial dimerization of the 
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protein they are attached to, whilst others (e.g. His-) are self-repelling thus hindering the natural 
dimerization of proteins they are attached to (Larijani et al., 2012). In principle, it is possible to 
cleave purification tags after or during the purification; however we and others have found that the 
extended time and incubation conditions of these procedures often result in the inactivation and 
aggregation of AID. A peculiarity of purifying enzymes, in contrast to other non-enzyme proteins, 
is that due to their innately mobile and transient protein structures, they typically ought to be frozen 
as soon as purified in order to preserve structural integrity and maintain enzymatic activity for 
further study (Larijani et al., 2009).  
 
1.3 Yeast protein expression system  
A wide range of host cells are available to produce recombinant proteins. The most common 
expression systems are prokaryotic and mammalian cell based (Rosano et al., 014; Wingfield 2015; 
Li et al., 2013; Terpe et al., 2006; Aricescu et al., 2006; Jia et al., 2016). For the last two decades, 
bacteria such as Escherichia coli have been the factory of choice for the simple low cost expression 
of the majority of proteins. However, the prokaryote lacks intracellular organelles needed for post-
translational modifications and therefore, is not able to properly fold and express many eukaryotic 
proteins, especially larger and more complex proteins (Jia et al., 2016; Sahdev et al., 2008). 
Alternatively, mammalians cells and other eukaryotic cells such as insect cells are popular choices 
to express eukaryotic proteins with high quality, but in lower amount since scaling up the cultures 
requires expensive infrastructure and media. In this light, yeast has been viewed as an attractive 
alternative eukaryotic expression system (Macauley-Patrick et al., 2005; Shobayashi et al., 2006). 
Compared with mammalian cells, yeast does not require a complex growth medium or culture 
conditions, is genetically relatively easy to manipulate, and has a similar protein synthesis pathway 
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(Wang et al., 2016; Ahmad et al., 2014). In the past decade, the methylotrophic yeast, Pichia 
pastoris (Komagataella phaffii), has been genetically engineered to produce hundreds of 
recombinant proteins important to industrial, pharmaceutical, and basic research purposes 
(Kurtzman 2009; Macauley-Patrick et al., 2005).  
There are many advantages of using P. Pastoris over other yeast strains for expression of 
heterologous proteins: it can be easily manipulated on a genetic level (Wang et al., 2016; Ahmad 
et al., 2014; Graf et al., 2009), does not undergo fermentation like Saccharomyces cerevisiae, can 
add many eukaryotic posttranslational modifications, and has a number of strong promoters 
available to drive protein expression intracellularly as well as in secreted form (Lin-Cereghino et 
al., 2005). Since P. pastoris secretes only small amounts of endogenous proteins, the secreted 
recombinant protein constitutes the vast majority of the total protein in the medium (Lin-Cereghino 
et al., 2008). P. pastoris grows quickly in a wide range of temperatures from 15°C to 30°C, and a 
pH ranging from 3.0 to 7.0 (Lin-Cereghino et al., 2008), thus providing a wide window of 
optimization for expression of each specific protein. Moreover, P. pastoris has an efficient 
methanol-inducible promoter from the alcohol oxidase I gene (AOX1) which is commonly used 
for foreign gene expression. A strong methanol inducible promotor from the AOX 1 gene, PAOX1 
can express a high level of recombinant protein compared to Alcohol Oxidase 2 promotor PAOX2. 
While AOX2 is about 97% homologous to AOX1, growth on methanol is much slower than with 
AOX1 (Tschopp et al., 1987; Kurtz et al., 1989; Cos et al., 2006; Graf et al., 2009). A characteristic 
attribute of this promoter is that it is strongly repressed in the presence of some carbon sources 
such as glucose and glycerol, but induced by methanol. Furthermore, P. pastoris’ preference for 
respiratory rather than fermentative metabolism, even at high-biomass, prevents the accumulation 
of secondary metabolites like ethanol and acetic acid which can be detrimental for cell growth as 
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well as damaging to the exogenously expressed protein. Finally, P. pastoris is a GRAS (Generally 
Recognized As Safe) organism, and can be grown in many different types of bioreactors (Noseda 
et al., 2014). Because of these characteristics, some proteins that cannot be expressed efficiently 
in bacteria, S. cerevisiae or the insect cell/baculovirus system, have been successfully produced in 
functionally active form in P. pastoris. (Lin-Cereghino et al., 2013).   
As with any expression system, choosing an optimal selection marker and promoter is essential 
for obtaining maximum protein quality and yield. To minimize the cytotoxic effects of AID we 
used the AOX1 promotor which has been the most widely utilized inducible promotor in 
pPICZ/pPICZα P. Pastoris-specific expression vectors. However, other promoter options such as 
constitutive GAP (glyceraldehyde 3-phosphate dehydrogenase) are also available for the       
production of foreign proteins in Pichia (Cos et al., 2006). Zeocin is a broad spectrum antibiotic 
that acts as a strong antibacterial and anti-tumor drug, shows strong toxicity against bacteria, fungi 
(including yeasts), plants and mammalian cells and is often used as a selection marker in yeast 
expression systems (Baron et al., 1992; Drocourt et al., 1990). P. pastoris is capable of integrating 
multiple copies of the vector DNA via recombination into its genome at sites of sequence 
homology. Like in S. cerevisiae, linear DNA can generate stable transformants of P. pastoris via 
homologous recombination between the vector DNA and regions of homology within the genome. 
Once integrants are identified by using a selection marker such as Zeocin on growth plates, they 
typically exhibit very stable gene expression even in the absence of selective pressure even when 
present as multiple copies (Pichia Expression kit Manual, Invitrogen, USA). Fig. 2 demonstrates 
selection marker and promotor in Pichia pPICZ/pPICZα vectors. The S. cerevisiae α- mating factor 
prepro-signal is the most widely used secretion signal, being in some cases a more efficient director 
of secretion than the leader sequence of the native heterologous protein (Cregg et al., 1993; Scorer 
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et al., 1993). However, variability in the number of N-terminal amino acids is commonly reported 
with heterologous proteins secreted using the α-factor prepro-leader (Kurjan et al., 1982). The α-
mating factor prepro-peptide signal leader consists of a 19-amino acid signal (pre) sequence 
followed by a 67-residue (pro) sequence containing three consensus N-linked glycosylation sites 
and a dibasic Kex2 endopeptidase processing site (Kurjan et al., 1982). Processing of the α-mating 
factor secretion signal occurs in three steps: first, the pre-signal is removed by signal peptidases in 
the endoplasmic reticulum; second, Kex2 endopeptidase severs the pro leader sequence between 
the arginine and lysine; and finally Ste13 protein rapidly cleaves the Glu-Ala repeats in the Golgi. 
As demonstrated in Fig.2, the small pre-signal is believed to be important for interaction with the 
signal recognition particle, subsequent translocation into the Endoplasmic Reticulum (ER), and 
folding of the nascent protein. (Lin-Cereghino et al., 2013; Kurjan et al., 1982). 
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Figure 2. Schematic representation of the yeast intracellular (pPICZnonα vector) and 
secretory expression (pPICZα vector) pathways. 
 Integration of the pPICZnonα and pPICZα vectors into the P. pastoris genome. Linear DNA can 
integrate into the genome of P. pastoris via homologous recombination to generate stable 
transformants. Gene insertion events at the AOX1 loci arise from a single crossover event between 
the loci and either of the two AOX1 regions on the pPICZnonα or pPICZα vectors (Double headed 
arrows). This results in the insertion of one or more copies of the vector upstream or downstream 
of the AOX1. Recombinant protein enters the endoplasmic reticulum (ER). Correctly folded 
proteins are transported to the Golgi for further processing including additional glycosylation. 
Proper signal sequences will guide recombinant protein for intracellular or secretory expression 
(yellow line: pre sequence, red line: pro sequence and blue line: recombinant protein). 
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1.4 Rationale and hypotheses  
Given the challenges of the bacterial and mammalian expression systems for AID expression, we 
sought to develop a novel yeast-based expression system for the study of AID. There are 4 basic 
reasons we believed this system could solve both the genotoxicity as well as purification hurdles 
that make AID purification difficult: first, yeast is a simple eukaryotic organism but its 
transcription and protein translation machinery has nearly the same level of sophistication as 
human cells. Second, compared with mammalian cells, yeast is easier to manipulate genetically 
(Macauley-Patrick et al., 2005) and can be grown quickly (Shobayashi  et al., 2006) with log-phase 
doubling times almost as low as that of bacterial cultures. Third, yeast has approximately a quarter 
of the total number of proteins as mammalian cells resulting in fewer non-specific interactions 
with AID thus facilitating purification. Fourth, yeast is an efficient secretor of proteins, allowing 
us to develop a novel secretion system. Our first hypothesis was that AID produced in yeast will 
be at least as robust in terms of activity as those produced in bacteria and mammalian cells. Our 
second hypothesis was that the secretion system will be immensely beneficial in the case of AID 
firstly because secreted AID can no longer inflict significant damage to the expression host cell 
genome, and secondly because yeast media is relatively free of other proteins and AID could 
potentially be harvested by simple concentration of the media, circumventing the need for protein 
tags, as is the current gold standard for AID/APOBEC purification. Our third hypothesis was that 
by studying untagged AID we will discover its true molecular properties which may prove to be 
different from the more artificially tagged versions studied thus far.   
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Material and Methods 
2.1 Workflow 
The overall experimental process used in this study is presented below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
2.2 Strains and plasmids 
P. pastoris (Komagataella pastoris) wild type strain (ATCC 28485) was used as a host for 
expression of fusion and non-fusion proteins and sub-cloning. E. coli TOP10 (Invitrogen, USA) 
and E. coli DH5α were used for the plasmid amplification. For this study we used pPICZα 
(Invitrogen, USA) and pPICZnonαB yeast expression vectors (Fig. 4). The vectors are identical 
except pPICZα contains an additional S. cerevisiae α-factor secretion signal sequence at the 
beginning of the insert protein gene, encoding for the yeast secretion marker α-factor protein. To 
eliminate the α-factor and create the pPICZnonαB vector, Site-Directed Mutagenesis method was 
used. Primers were designed to anneal to the parent plasmid and make an EcoR I digestion site 
(GAATTC) at the beginning of the α-factor sequence. We used EcoR I because there was already 
an EcoR I downstream of alpha factor gene, and because it does not cut elsewhere on the plasmid 
Mutagenesis was performed according to the manufacturer's directions. Briefly, primers were 
diluted to a concentration of 60 ng/μl and the following reaction mixture was set up: 10 μl of 5× 
reaction buffer, 5 ng parent plasmid, 2 μl of each primer, 1 μl of 10 mM dNTP, 1 μl of Pfu DNA 
polymerase (NEB), and sterile water to a final volume of 50 μl. Cycling parameters for the reaction 
were: 1 cycle of 96 °C for 1 min; 35 cycles of 95 °C for 30 s, 58 °C for 30 s, 72 °C for 4 min, 
followed by a single cycle of 68 °C for 10 min. After the reaction was complete, 0.75 μl of DpnI 
was added directly to the reaction mix and incubated at 37 °C for 4 h to destroy the methylated, 
parental DNA. Finally, 5 μl of the digested reaction mix was transformed into E. coli DH5α 
chemically competent cells and transformants were plated on LB agar plates supplemented with 
Zeocin. To confirm the site-directed mutagenesis at the α- factor region, several colonies from 
each construct were sequenced and then digestion was preformed using EcoR I to delete full α- 
factor sequence. 
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2.3 Construction of GST-AID, AID-V5-His and untagged AID expression vectors 
Full sequences and details of vector construction are shown in the appendix of this thesis. We used 
PCR to amplify AID containing either an N-terminal GST tag, a C-terminal His tag as well as only 
the native ORF sequence with no tags. To control for the protein expression and purification, we 
used a GST-only expressing construct that produced a GST-V5-His fragment. We have previously 
generated this control protein, since it is an inert protein and contains 3 epitopes making it useful 
as a universal control for expression of any protein that is tagged with GST, His, or V5 epitopes, 
or any combination. PCR amplicons were cloned into the pPICZα/nonαB expression vectors using 
GAATTC restriction sites for EcoR I. The genes of interests and pPICZα/nonαB were digested 
with EcoR I in the separate reactions. After 1% agarose gel electrophoresis, AID fragments and 
the pPICZα/nonαB fragments were gel recovered and ligated overnight at 16 ˚C with T4 DNA 
ligase. The resultant recombinant expression GST-AID, AID-V5-His and untagged AID- 
pPICZα/nonαB were finally transformed into E. coli DH5α and selected on Low Salt LB agar 
plates containing 25 μg/mL Zeocin at 37 ˚C for overnight. We then sequenced these plasmids and 
identified multiple correct clones bearing either the GST-AID, AID-V5-His or untagged AID 
inserts in each vector.   
2.4 Transformation of GST-AID, AID-V5-His and untagged AID- pPICZα/nonαB into  
P. pastoris 
The constructed GST-V5-His, GST-AID, AID-V5-His and untagged AID- pPICZα/nonαB 
plasmids were linearized by Sac I and transformed into P. pastoris cell which is capable of 
integrating this linearized DNA into its genome in a long term stable fashion by chemical 
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transformation (Invitrogen, USA) according to a previously described procedure. Briefly,                  
P. pastoris cells were chemically competent and transformed with 3 μg of linearized plasmids 
harboring the gene of interests using heat shock and chemical solutions II (PEG solution) and III 
(salt solution) from EasyCom kit (Invitrogen, USA). Single colonies of the transformants were 
selected on selective YPDS (1% yeast extract, 2% peptone, 2% dextrose, 1mol/L sorbitol and 2% 
agar) plates containing 100 μg/mL Zeocin for expression. We identified colonies that had 
successfully integrated our expression vectors into their genomes. Subsequently, AID expression 
from the positive colonies was confirmed the expression of our AID proteins using Western blot 
with either anti GST- , V5- or -AID specific antibodies. To lyse the cells, cultures were centrifuged 
and yeast cell pellets bearing pPICZnonαB vectorwere lysed using glass beads (425-600 μm, 
Sigma-Aldrich). An equal volume of glass beads was then added, by estimating volume by 
displacement. The mixture was then vortexed for 30 seconds, then incubated on ice for 30 seconds. 
This was repeated 5-7 more times in standard protein lysis buffer. Then, 20-25 μl of cell lysate or 
20-25 μl of concentrated cell (bearing pPICZα vector) free medium (5-fold concentrated using a 
Vivaspin-2 column) were applied to Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS–PAGE). 
SDS–PAGE was performed on 10% stacking and running gels. After electrophoresis, the proteins 
were transfered to Nitrocellulose membrane (Biorad). The membrane was washed with Tris buffer 
saline Tween 20 (TBST). 5% Skim milk powder in TBST was used as a blocking solution for 1h 
at room temperature. Western blots were probed with anti-V5 and anti-rabbit polyclonal AID 
(Abcam) or anti-GST (SantaCruz) antibodies (1/5000 diluted of each), followed by the secondary 
detection by Goat anti-Rabbit IgG (SantaCruz) in TBST and 5% Skim milk powder. The reaction 
was stopped by repeated TBST wash after each probing. Color development was carried out by 
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western blotting detection reagents. The Band Analysis tools of ImageLab software version 4.1 
(Bio-Rad) were used to select and determine the background-subtracted density of the bands in all 
the gels and blots. We used SDS-PAGE as a semi-quantitative estimate of the GST-V5-His piece 
concentration. We created a standard curve with a protein of known concentration bovine serum 
albumin (BSA) standard curves to compare against. Quantification was done by densitometry. 
Different concentration of BSA 0.5, 1, 1.5 and 2 μl of 0.5mg/ml as standard and 15, 17.5, 20 and 
25 μL of GST-V5-His protein were used. Gels were stained with Coomassie and the band 
intensities estimated using ImageLab software version 4.1 (Bio-Rad). A standard curve was 
created by plotting intensity as a function of mass, from which concentration of the GST-V5-His 
was found. 
Subsequently, known amounts of GST-V5-His (0.02 μg/μl) were used in Western blots and 
utilized to quantitate the yeast-expressed AIDs. We used this standard protein, since it can be 
probed with both anti-GST and anti-V5 antibodies and it is thus suitable for quantification of any 
GST- or V5-tagged protein. For measurement of untagged AID, we first quantified AID-V5-His 
based on GST-V5-His on another gel with either anti-V5 or GST antibodies. Then untagged AID 
was measured based on the known AID-V5-His concentration using anti-AID antibody.  
 
2.5 AID expression and purification  
The expression vectors pPICZα/nonαB harbor GST-AID, AID-V5-His, untagged AID and GST-
V5-His were induced to express AID or GST piece with methanol in yeast. The recombinant              
P. pastoris clone, was inoculated into 10 mL YPD (1% yeast extract, 2% peptone and 2% dextrose) 
at 30 ◦C, 250 rpm, for about 16 h. Then 1 mL culture supernatants was inoculated into 100mL 
BMGY medium 1% yeast extract, 2% peptone, 100 mmol/L potassium phosphate, pH 6.0, 1.34% 
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YNB (yeast nitrogen base without amino acids), 0.005% biotin and 1% glycerol) in 250 mL baffled 
flasks. The cultures were grown at 30 ˚C, 250 rpm for 24–32 h. Cells grown in BMGY were 
harvested and re-suspended in 100 mL BMMY (1% yeast extract, 2% peptone, 100 mmol/L 
potassium phosphate, pH 6.0, 1.34% YNB, 0.005% biotin and 0.5% methanol), then 0.5% final 
concentration of methanol was added to induce protein expression at 30 ˚C with constant shaking 
at 300 rpm. To induce the expression of the target protein, 100% methanol was added to a final 
concentration of 0.5% (v/v) every 24 h due to methanol evaporation. At each of the times: 0, 6, 12, 
18 and 24 hours, 1 ml of the expression culture was taken. Cell pellets bearing pPICnonαB vector 
and medium separately were used to analyze expression levels and determine the optimal time 
post-induction to harvest. Cells were re-suspended in PBS with 0.2 mM PMSF, 50 μg/ml RNAse 
and lysed using a French Pressure cell, followed using the French pressure cell press 
(Thermospectronic) and purification using Glutathione Sepharose high-performance beads 
(Amersham) as per manufacturer's recommendations. Beads were washed with PBS and were 
stored in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM dithiothreitol.  
For AID-V5-His cells were resuspended in the lysis buffer 50 mM Phosphate Buffer pH 8.2 and 
500 mM NaCl, 0.2 mM PMSF, 50 μg/ml RNAse A and lyse using the French pressure cell press 
and batch binding on Nickel Sepharose beads (Amersham) as per manufacturer's 
recommendations. Beads were serially washed with lysis buffer containing increasing 
concentrations (1 mM and 30 mM) of Imidazole, and eluted in lysis buffer containing 500 mM of 
Imidazole. Alternatively, washed beads with bound AID-V5-His were stored in AID storage buffer 
as a source of bead-bound AID. All purifications were subjected to analysis by coomassie staining 
and Western blot, to verify the relative yield and purity of AID. Western blots were probed with 
anti-V5 and rabbit polyclonal AID (Abcam) or anti-GST (SantaCruz) antibodies, followed by the 
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secondary detection by Goat anti-Rabbit IgG (SantaCruz) same as above protocol. Three 
independently purified and cell lysate for untagged preparations were used in this study. 
 
2.6 preparation of substrates  
Single-stranded bubble substrates for AID enzyme assays were prepared as described (Larijani et 
al., 2007; Larijani et al., 2007). Briefly, DNA oligonucleotides were synthesized and subject to 
HPLC purification (IDT) and 2.5 nM of the target oligonucleotide was 5'-labeled with [γ-32P] 
dATP using polynucleotide kinase (New England Biolabs). The labelled oligonucleotide 
containing the target dC residue was purified through mini-Quick spin DNA columns (Roche) and 
annealed with 3-fold excess cold strand in a total volume of 50 μl, with incubation starting at 96 
°C and slow cooling at 1 °C/min to 6 °C. Triplex bubble structures were prepared by mixing the 
labeled strand, the cold strand of the same length and shorter complimentary strand at a ratio of 
1:3:9. Incubation started at 96 °C and slow cooling at 1 °C/30 sec to 6 °C  
 
2.7 Alkaline cleavage deamination assay for AID activity  
This assay has already been described (Sohail et al., 2003; Larijani et al., 2007; Dancyger et al., 
2012) and was used to measure and quantify the catalytic activity of AID. Briefly, to determine 
substrate specificity, each AID was incubated with 2.5 nM radioisotope labelled bubble substrates 
with the following target sequence: TGC, TAC, AGC, GGC, GAC, or GTC in 100 mM phosphate 
buffer pH 7.21 at 32 °C for 2 hours. To determine time-point kinetics, 2.5 nM radioisotope 
TGCbub7 as a labelled substrate was incubated with 12-20 ng AID for time periods 3, 5, 10, 15, 
30, 60, 120, 180 min in 100 mM phosphate buffer pH 7.21 at 32 °C and 37 °C. Fmol deaminated 
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substrate/µg AID was plotted against time incubated. These experiments were used to determine 
the time of the initial exponential phase of AID activity, in order to proceed to Michaelis-Menten 
kinetics. Enzyme kinetics were then performed using a range of labelled TGCbub7 substrate 
concentrations including 7.5, 5, 4, 2.5, 1.25, 0.625, 0.315 and 0.15 nM in a total volume of 10 μL 
per reaction tube in 100 mM phosphate buffer pH 7.21 incubated with 12-20 ng AID, at 32 °C and 
37 °C for 4 hr. Percentage deamination was used to calculate velocity (fmol product/min 
incubation/µg AID), which was then plotted against substrate concentration. 2–3 independent 
preparations of each AID were tested in 2–3 individual experiments. 
Negative controls were reactions with substrate and no enzymes, substrate with mother vectors, 
untransformed yeast and GST-V5-His fragment. Positive controls were reactions containing 
enzymes previously purified and known to be active from bacterial (B-GST-AID) or mammalian 
systems (M-AID-V5-His). A master mix of 7.8 μL H2O, 2 μL 10X UDG buffer and 0.2 μL UDG 
enzymes (NEB, USA) was incubated with the previous reaction for 30 minutes to excise the 
uridine. The total reaction volume is now 20 μl. 2 μl of 2 M NaOH (fresh; 200 mM final) was then 
added and temperature was increased to 96°C for 10 minutes to cleave the alkali-labile abasic site. 
Immediately before loading the gel, 8 mL of formaldehyde loading dye were added to each reaction 
and incubated at 96°C for 5 minutes. Samples were loaded on a 14% polyacrylamide denaturing 
gel (1X TBE, 25% Formamide, 14% acrylamide:bisacrylamide, 7M Urea) and run at 200-300 V 
until the dye front travelled approximately halfway down the gel. The resolved gels were exposed 
to a blanked Kodak Storage Phosphor Screen GP (Bio-Rad) and imaged using a Phosphor Imager 
(Bio-Rad, Hercules, CA, USA). Quantitation was done using an Image Lab™ 4.1 and Quantity 
One 1-D Analysis Software (Bio-Rad, Hercules, CA). 
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2.8 Deamination specific PCR assay 
The plasmid construct used as a substrate is pcDNA3.1 V5-6xHIS containing a random target 
sequence. The plasmid was isolated by maxiprep (Qiagen), followed by purification of the 
supercoiled fraction through Cesium chloride gradient centrifugation. 50 ng of plasmid was 
denatured at 98 °C in 100 mM phosphate buffer pH 7.21 for 10 min followed by snap-cooling in 
an ice bath. 4 μl concentrated supernatant (cell free medium) of AID-V5-His and untagged AID 
from pPICZα and 4 μl  of GST-AID, AID-V5-His and AID (12 ng of GST-AID,  18 ng of AID-
V5-His and 20 ng untagged AID from pPICZnonαB  were added to the reactions and incubated 
for 4 h at 32 ˚C. To detect AID-mediated mutations, 1 μl of each reaction was amplified by 
deamination-specific nested PCR using Taq DNA polymerase and mutation-specific primers, as 
previously described (Larijani et al., 2005). 
 We used following primers for this assay. A3D sense fwd 4: 5'-GGG ATA TAG GGG TTT TTT 
GAG GTT TGG TAT TAT TTA AAT- 3' and A3D sense rev 2: 5'-ACA CAA CCA ACT TTC 
AAT CCA ACC ACA ACC ACA ACC AAC TTT CAA TA-3'. A3D sense fwd 5: 5'-TTT ATT 
TTG GTT TTG TGG TAA TTG ATT GTT TGT TAA TAG G-3', A3D sense rev 3: 5'-CCA ACT 
TTC ATT CCA ACC ACA AAC TTT CAA TAA ATT-3'. 
Each reaction contained: 10 μM of the forward and reverse primers (IDT Inc), 10 mM dNTP 
(Invitrogen), 1 μl deamination reactions, Taq DNA polymerase and 10x PCR buffer (100 mM Tris 
pH 8.3, 500 mM KCl, 15 mM MgCl2). The nested PCR reactions were 37 cycles of 94 ˚C for 30 
seconds, 59 ˚C for 30 seconds, 72 ˚C for 1 min, with A3D sense fwd 4 and rev 3 primers, followed 
by a second round of PCR using 1 μl of sample from the first round, with primers A3D sense fwd 
5 and rev 2 and an annealing temperature 58 ˚C. Some plasmid substrates are mutated by AID at 
different levels, while others are unmutated. The first type of PCR in the nested PCR has 
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deamination-specific primers and therefore selectively amplifies AID-mutated DNA. The inner 
primers used in the nested PCR reaction generate a 451 nt-product. PCR products were analysed 
on an 1% agarose gel and the 451 nt-long PCR amplicons was subsequently TA-cloned, and 10 
amplicons from each reaction were sequenced to confirm AID-mutated mutations C to T, or G to 
A on the sense and non-sense strands, respectively. This experiment has been done once. 
 
2.9 AID activity data quantification and statistical analysis   
Band densitometry was performed as previously described (Abdouni et al., 2013). Briefly, Image 
Lab™ 4.1 analysis Software (Bio-Rad) was used to measure and compare the densitometry of the 
deaminated product band and the substrate band. Using these values, the relative amount of 
deaminated product (as a percentage of the total non-deaminated and deaminated bands) was 
derived. Background values are automatically determined by Image Lab, and were also manually 
determined from negative control lanes and subtracted from reaction lanes. For independent 
confirmation, each individual lane of an alkaline cleavage was also quantified three times using 
Quantity One 1-D Analysis software (Bio-Rad, Hercules, CA) to ensure the accuracy of data 
analysis. Typically, each experiment was repeated 2-5 times using at least 3 independently purified 
preparations of each type of purified AID. The GraphPad Prism software (GraphPad, San Diego, 
CA, USA) was used to graph and analyze the obtained data. Error bars represent standard 
deviation.   Paired T-test in GraphPad Prism was used to analyze data to calculate the significance 
of differences in the activities of different versions of AID at different temperatures and time 
points.  
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Results 
 
3.1 Demonstrating feasibility of expression and subsequent purification of AID in the yeast 
system  
Fig. 3 shows our overall experimental strategy. Briefly, the expression of any foreign gene in yeast 
entails 3 principal steps: first, the insertion of the gene of interest into an expression vector and 
transformation into yeast cells (Fig. 3, top left), second, the selection of strains that express the 
foreign protein and third, scaling up the culture to obtain enough protein either in cell pellets for 
intracellular AID (Fig. 3 bottom left), or in media to obtain secreted AID (Fig. 3 bottom right). 
The sample then proceed to the purification step.  
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Figure 3. Schematic of the key steps in expression and purification of AID in yeast. 
Recombinant proteins including human GST-AID, AID-V5-His and untagged AID were 
expressed, with and without the α-factor secretion signal at the N-terminus. The pPICZ vector 
contains a Zeocin resistance gene for selection in both E. coli and Pichia (a and b). Initial colony 
selection was carried out using Zeocin. Small scale expression trials with methanol induction 
carried out in 25 mL culture volume (c). Expression of GST-AID, AID-V5-His and untagged AID 
in yeast was scaled up and proteins were purified intra- (d) in pPICZnonαB vector and extra-
cellular (secreted) in pPICZαB vector (e). Cell free medium was concentrated using a Vivaspin-2 
column to collect secreted heterologous protein (f). Cell pellets were harvested and lysed to detect 
intracellular GST-AID, AID-V5-His and untagged AID (g). Cell pellets were lysed in a French 
pressure cell press and the supernatant was directly subjected to an activity assay (i) or applied to 
a column of both Glutathione-Sepharose high-performance and Nickel beads (h). 
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3.2. Construction of expression plasmids and selection of the recombinant P. pastoris clones 
We obtained the expression construct pPICZα vector which is designed for the production of 
secreted proteins. It contains the α-factor signal which is the most widely used secretion signal in 
yeast and is in some cases a more efficient signal for secretion the leader sequence of the native 
heterologous proteins. This 89 amino acid long signal peptide is cleaved in two stages, first in the 
endoplasmic reticulum and then in the Golgi apparatus, resulting ultimately in secretion of the 
protein to which it was attached. To be able to generate both secreted as well as intracellular AID, 
we first modified the vector by removing the secretion signal sequence α-factor. This was achieved 
using restriction digestion sites flanking this region. To be able to excise the region encoding the 
α-factor, we introduced these restriction site for EcoR I through routine site-directed mutagenesis 
(Figs. 4a, b and c). We generated the non-secreted pPICZnonαB vector from parental vector 
pPICZαB. GST-His-V5, AID-V5-His and untagged AID open reading frames were then cloned 
into both versions of the expression vector, pPICZαB or in pPICZnonαB by routine DNA 
manipulation (Table 2 and appendix). Thus, we constructed intracellular Y-GST-AID, intracellular 
Y-AID-V5-His and intracellular Y-AID, which are in the pPICZnonαB vector, and secreted Y-
AID and secreted AID-V5-His which are in the pPICZαB vector (Y letter indicates that preps are 
from yeast).  
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Figure 4. Schematic of representation of yeast secretion vector pPICZαB and yeast 
intracellular expression vector pPICZnonαB with 5' AOX1 promotor.  
(a) Schematic of the pPICZαB vector which contains a secretion signal (α-factor), adapted from 
Invitrogen, USA. (b) The α-factor secretion signal sequence for directing secreted expression of 
the recombinant protein in the pPICZαB vector. The α-factor in this vector is flanked by a single 
EcoR I digestion site. To remove α-factor sequence we created a second EcoR I digestion site by 
standard site directed mutagenesis on the other side of the α-factor-encoding sequencing and were 
able to generate a new non- α-factor vector through EcoR I digestion. (c) Schematic of the 
pPICZnon α-factorB vector.  
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Table 2. Constructs in pPICZα/nonαB expression Pichia Vector. z 
The α-factor-AID-V5-His, α-factor-GST-AID, α-factor-untagged AID- and α-factor-GST-V5-His 
expression vectors were constructed by cloning cDNA into the pPICZαB vector using the EcoR I 
digestion site. AID-V5-His, GST-AID, untagged AID and GST-V5-His were cloned in 
pPICZnonαB in the same method. Mother vector pPICZαB expressing α-factor and pPICZnonαB 
were used as controls. 
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3.2 Expression and purification of the recombinant AID enzymes 
The recombinant plasmids pPICZα/nonαB-AIDs were transformed into P. pastoris. Linear DNA 
can generate stable transformants via homologous recombination. Methanol induced cultures were 
collected every 6 h. Cell free supernatants were 5-fold concentrated using a Vivaspin-2 column. 
Cell pellets were extracted into SDS sample buffer using glass beads (425-600 μm, Sigma) by 
vortexing and interval incubating on ice. All samples were subjected to Western blot using anti- 
V5 epitope, anti-GST and anti-AID antibodies. We detected a main protein band of 24 kDa for 
untagged AID and 52 and 29 kDa for AID-V5-His and GST-AID, respectively (Figs. 5a, b and c), 
which are the expected sizes of each protein.  
The expression of the recombinant AID enzymes reached a detectable level at around 18 h. We 
successfully expressed intracellular Y-GST-AID, intracellular Y-AID-V5-His and intracellular Y-
AID also secreted Y-AID and secreted Y-AID-V5-His in P. pastoris. Direct quantification of 
expressed proteins on SDS- PAGEs was impossible because of their low concentration; therefore, 
we developed a semi-quantified Western blot-based method. In this method, quantification of 
protein expression was carried out based on a GST-V5-His standard curve for purified Y-GST-
AID and Y-AID-V5-His and indirectly based on quantified AID-V5-His for untagged AID (Y-
AID). Different concentration of proteins were detected with anti-AID antibody. The GST-V5-His 
concentration and size standard were first quantified based on a BSA standard curve on 
coommassie-stained SDS-PAGE (Fig. 5c) . Subsequently, known amounts of GST-V5-His were 
used in western blots and utilized to quantitate the yeast-expressed AIDs. We used this standard 
protein, since it can be probed with both anti-GST and anti-V5 antibodies and it is thus suitable 
for quantification of any GST- or V5-tagged proteins. For measurement of untagged AID (Y-AID), 
we first quantified Y-AID-V5-His or Y-GST-AID based on GST-V5-His on another gel with either 
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anti-V5 or GST antibodies. Then untagged AID (Y-AID) was measured based on the known AID-
V5-His or GST-AID concentration using anti-AID antibody.The Band Analysis tools of the 
ImageLab software version 4.1 (Bio-Rad) were used to select and determine the background-
subtracted density of the bands in all the gels and blots. We obtained 3, 4.5 and5 ng for AID-V5-
His, GST-AID and untagged AID, respectively. Although we observed the expression of untagged 
intracellular AID in pPICZnonαB using Western blot (Fig. 5d), we could not identify untagged 
secreted AID from the secretion vector pPICZαB due to its low concentration; however, we are 
confident that the secreted AID is present in the medium because we were able to detect activity 
using a deamination PCR assay and an alkaline cleavage assay.  This activity was neither observed 
on extracts of yeast transformed with empty expression vector, nor in extracts of untransformed 
yeast.   
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
35 
 
Figure 5. Successful expression and purification of AIDs in yeast detected by Western blot. 
Yeast cultures were grown with methanol in the media to induce AID expression. Cultures were 
centrifuged and yeast cell pellets were lysed using glass beads in standard protein lysis buffer and 
supernatant concentrated by a Vivaspin-2 column, electrophoresed on SDS-PAGE protein gels. 
Western blotting was carried out and blots were probed with anti-V5 antibodies. (a) Representative 
gel shows successful expression and secretion of AID-V5-His and GST-V5-His at the expected 
sizes of 48 kDa and 32 kDa respectively. The size is confirmed using a mammalian-purified M-
AID-V5-His as size control. Cell lysate and supernatant of untransformed yeast as well as Pichia 
expressed mother (in pPICZα/nonαB) vectors were used as negatives. (b) successful purification 
of  intracellular Y-GST-AID and intracellular Y-GST-V5-His as an example, the size was 
confirmed by running a purified B-GST-AID (bacterial) on the same gel.The negative control a 
culture that was not transformed with the AIDs expression vector. (c) Coomassie stained gel 
showing purification and expression of GST-V5-His. Coomassie gel also contains varying BSA 
for measurement of GST-V5-His. (d) An example of an indirectly semi-quantification of 
intracellular Y-AID-V5-His and intracellular untagged AID(Y-AID) by Western blotting. 
Untagged AID (Y-AID) was indirectly semi-quantified based on Y-AID-V5-His or Y-GST-AID 
standard curves. Briefly, since GST-V5-His contains 3 different epitopes (GST, V5 and His) it 
easily can be quantified using anti GST, V5 or His on Western blot. First the concentration of 
purified GST-V5-His was determined through visualization on SDS-PAGE based on the BSA 
standard curve. Then, known amounts of GST-V5-His (0.02 μg/μl) were used in western blots to 
verify the relative concentration of either GST or V5- His AID enzymes using anti V5-epitope or 
GST antibodies. Next, based on quantified GST-AID or AID-V5-His we estimated the 
concentration of untagged AID (Y-AID) using anti-AID antibody. 
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3.3 All versions of AID from yeast are active 
Having determined that all versions of yeast-expressed AID were successfully expressed, we tested 
their cytidine deaminase activity. We applied the standard alkaline cleavage assay for cytidine 
deamination, which we and others have previously established to measure AID activity on ssDNA 
(Petersen-Mahrt et al., 2003; Dnacyger et al., 2012; Abdouni et al., 2013; Larijani et al., 2003). 
We incubated each AID at 37°C with a partially single-stranded bubble substrate containing a 7 
nucleotide long ssDNA region with the AID-preferred WRC motif TGC (Fig. 6a). This substrate 
was chosen since we have previously shown that it is the most preferred substrate of purified AID 
amongst a panel of hundreds of different ssDNA shapes and sequences.  
We found that all versions of our yeast-expressed AID can deaminate dC efficiently (from 5 % to 
54%) on TGCbub7, including fusion and non-fusion tags in secretion vector pPICZαB and 
intracellular expression vector pPICZnonαB from yeast (intracellular Y-AID, intracellular Y-AID-
V5-His, intracellular Y-GST-AID, secreted Y-AID and secreted -Y-AID-V5-His). This activity 
was not observed on any of the negative controls including yeast extracts transformed with empty 
expression vectors, untransformed yeast or a GST-V5-His fragment (Fig. 6b), providing 
confidence that the activity observed in the alkaline cleavage assay represents bona fide AID-
mediated cytidine deamination. Not only did we show that all AID versions expressed in yeast are 
active, but also this is the first time that deaminase activity has been detected from untagged AID.  
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Figure 6. All AID versions are active.  
(a) Partially single-stranded bubble substrate used in alkaline cleavage deamination assay 
TGCbub7. This substrate is 56 nt in length and comprises a 7 nt long single-stranded bubble region 
that has cytidine, the arrow indicates the target cytidine; asterisk indicates the radioactively labeled 
strand. (b) 25 fmol TGCbub7 was incubated with 12-20 ng of intracellular AID and 4 µL 
concentrated cell free media for secreted AID  in 100 mM activity buffer (final volume 10 µL) for 
2 hrs at 37 °C. A representative alkaline cleavage gel is shown.  Different forms of AID from yeast 
can efficiently deaminate dC in context of TGC sequence. The presence of a band in all expressing 
yeast extracts (intracellular Y-AID, intracellular Y-AID-V5-His, intracellular Y-GST-AID, 
secreted Y-AID and secreted Y-AID-V5-His) indicates enzyme activity. Previously purified 
mammalian (M-AID-V5-His) and bacterial produced AID (B-GST-AID) were used as positive 
controls, negative controls included a reaction with no enzyme added to a reaction containing yeast 
extract from a culture of yeast that was not transformed with AID expressing vectors and cell 
extractions of yeast expressing empty pPICZα/nonα B vectors as well as the GST-V5-His 
fragment. 
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3.4 All version of AID expressed in yeast maintain AID’s bona fide sequence preference   
AID preferentially deaminates cytidines within WRC (W = A or T, R = A or G) hot-spot motifs 
(Sohail et al., 2003; Larijani et al., 2005; Dancyger et al., 2012; Larijani et al., 2007; Greisman et 
al., 2012; Lu et al., 2013 ). Although AID/APOBEC can mutate any given dC in ssDNA, each 
AID/APOBEC enzyme has a unique three or four nucleotide-long preferred motif, or “hotspot”, 
based on the -2 and -1 dinucleotide immediately upstream of the target dC. Since these signature 
trinucleotide hotspots are unique, they serve as the main barcode used to determine which 
AID/APOBEC family enzyme(s) have acted upon a given cellular or viral genome. For instance, 
AID's favoured target is the trinucleotide WRC (W=A/T, R=A/G), and these hotspots are the 
sequence motifs targeted by purified AID in vitro, AID exogenously expressed in bacteria or cell 
lines, as well as bona fide AID activity in vivo in antibody diversification as well as its off-target 
genome-wide mutagenesis.  
Given the importance of their sequence specificity in their genomic targeting and off-targeting, it 
is a topic that has been intensely studied, using mutagenesis and chimeric approaches at the 
structural level. We and others have previously shown that the core catalytic pocket architecture 
responsible for accommodating and deaminating the dC nucleotide is well conserved within the 
AID/APBOEC family. The trinucleotide specificity is mediated by specific regions on the surface, 
proximal to the catalytic pocket, as mediated by a substrate specificity loop, which is highly 
divergent amongst family members. It has been shown that swapping this loop between various 
family members can transfer the sequence specificity of the donor, and that differences in the 
length and amino acid sequence of this substrate specificity loop yield varying surface topologies 
next to the catalytic pocket, which have been suggested to result in differing preferences for 
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accommodation of pyrimidine or purine bases at the -2 and -1 positions relative to the target 
cytidine.  
To test whether AID expressed from yeast in different types has a similar sequence specificity to 
AID purified in mammalian and bacterial systems using different fusion tags, we tested its WRC 
specificity using our standard alkaline cleavage deamination and deamination specific PCR assays. 
We tested AID on 6 different oligonucleotide substrates that are identical to TGCbub7 substrate 
(Fig. 7a) except for the -2 and -1 position nucleotides immediately upstream of the target dc 
forming either WRC motifs (hot spots; -TGC-, -AGC- and –TAC- ) or non-WRC motifs(cold 
spots; -GGC-, -GTC- and –GAC-) (Fig. 7a).   
We found that intracellular Y-AID was almost 3.5-fold more active on WRC motifs (TGC: 54%, 
TAC: 41%, AGC: 34% than on non-WRC motifs (GGC: 17%, GTC: 12.5%, GAC: 8%). We found 
that intracellular Y-AID-V5-His was almost 2.7-fold more active on WRC motifs (TGC: 23%, 
TAC: 32%, AGC: 21%) than on non-WRC sequences (GGC: 15%, GTC: 5.3, GAC: 7.5). 
Intracellular Y-GST-AID showed on average 28% activity on WRC sequences, while it did not 
exhibit any activity on non-WRC sequences. Since the secreted AID enzymes including Y-AID 
and Y-AID-V5-His only deaminated TGC and TAC (5% deamination), we failed to calculate 
deamination efficiency ratio for them (Fig. 7b). Since WRC specificity is highly sensitive to the 
conformation of the enzyme’s catalytic pocket and surrounding surface regions, the substrate 
specify confirmed our notion that yeast can properly express and fold the AID protein, and 
accurately folded near to the pocket and on the surface AID.  
 
 
 
41 
 
 
42 
 
Figure 7. Enzyme assay and substrate specificity demonstrating AID enzymes produced in 
yeast exhibit WRC preference.   
We tested the activity of yeast concentrated supernatant Y-AID and Y-AID-V5-His, intracellular 
Y-GST-AID, intracellular Y-AID-V5-His and intracellular Y-AID using the standard alkaline 
cleavage assay for measuring cytidine deaminase activity and substrate preference of 
AID/APOBEC enzymes. (a) All substrates used in activity assays contain a single cytidine within 
the bubble and differ only in the dinucleotide in the -2 and -1 positions immediately upstream of 
the target cytidine constituting either WRC motifs (hot spots; -TGC-, -AGC- and –TAC-) or non-
WRC motifs (cold spots; -GGC-, -GTC- and –GAC-), the arrow indicates the target cytidine; 
asterisk indicates the radioactively labeled strand. (b) The histogram shows substrate specificity 
of each AID on six bubble substrates (Deamination percentage) with the following target sequence: 
TGC, TAC, AGC, GGC, GTC, and GAC. Error bars show s.d. from three independent 
experiments. 
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3.5 Complete trinucleotide mutability index of different types of AID from yeast 
To confirm deaminase activity of AID enzymes we applied the deamination-specific PCR assay 
which can be used to reliably compare relative amounts of plasmid DNA mutated by purified AID 
(Larijani et al., 2005; Larijani et al., 2012). In this assay, a target plasmid is made single-stranded 
by heat denaturation and incubated with AID. Following this incubation, AID-mutated sequences 
are specifically amplified by PCR using primers that preferentially bind to deaminated plasmid 
DNA. The target plasmid was boiled, snap-cooled then incubated with AID enzymes. When the 
target plasmid was incubated with the extract of yeast transformed with the mother vector or 
untransformed yeast negative controls, no amplification using the deamination-specific primers 
was observed (Fig. 8a, top panel); therefore, the PCR-amplified bands from the AID incubations 
can be attributed to specific AID-mediated dC to dU conversion. To determine the preferred 
sequence context mutated by AID enzymes, AID-treated PCR products were cloned and 
sequenced. Our analysis specifically focused on the mutability index of trinucleotide motifs 
(Larijani et al., 2005). Secreted Y-AID-V5-His deaminated cytidine in AAC and GTC motifs at a 
higher levels than other motifs and while no activity on GCC and TCC was detected (Fig 8b). 
Intracellular Y-AID-V5-His showed deamination activity on all motifs except for CTC and GTC 
and less deamination on GCC and GAC, which was almost the same as the secreted Y-AID except 
it deaminated CTC at a very low level (Figs 8c and d). Intracellular Y-AID preferred TTC, TGC, 
GAC, TAC, TCC, CGC, GGC and AAC motifs and no activity on GTC, respectively low activity 
on GCC and CCC was observed (Fig 8e). Intracellular Y-GST-AID did not mutate GGC, GCC, 
GTC, AGC and CGC, and it deaminated CCC less than others (Fig. 8f).  
Overall, cytidine deaminase activity in the alkaline cleavage assay as discussed in the preceding 
sections is apparent from the presence of a specific cleaved product; however, direct sequencing 
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of C to T mutations in amplicons obtained in the PCR assay provides undisputable and direct proof 
that all AID enzymes from yeast are active and can deaminate dC. Moreover, we confirmed that 
in general, the yeast AID preparations maintained WRC specificity, despite variations in the degree 
of this preference amongst the different AID forms (Fig. 8b). 
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Figure 8. Different versions of AID show activity in deamination specific PCR assay.  
(a) A representative AID deamination specific PCR assay gel for all AID enzymes expressed in 
yeast. The target denatured plasmid was incubated with AID. The reactions were then subjected to 
nested PCR with primers specific to the target plasmid with either T or A substituted for C or G, 
respectively, which selectively amplify AID-mutated DNA. The inner primers used in the nested 
PCR reaction generate a 451 bp-product. The agarose gels were stained with ethidium bromide 
and photographed with colors inverted. Trinucleotide mutability indices of purified and 
concentrated AID from yeast. The y axis shows the mutability index for all 16 NNC motifs. 
Relative preference for each individual NNC sequence was obtained by dividing its mutation rate 
by the average value for all 16 NNCs. The x axis shows NNC DNA motifs. (b) Secreted Y-AID-
V5-His (c) Intracellular Y-AID-V5-His (d) secreted Y-AID (e) Intracellular Y-AID (f) 
Intracellular Y-GST-AID. This experiment has been done only once.  
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3.6 Comparison of the catalytic kinetics of different types of AID from yeast  
We investigated the catalytic rates of AID from yeast by comparing Michaelis-Menten enzyme 
velocities. In order to determine the optimal duration of incubation with substrate for each AID 
enzyme to measure initial catalytic velocities, we first performed time course enzyme kinetics 
comparisons. TGCbub7 was incubated for various time points (3, 5, 10, 15, 30, 60, 120 and 180 
min) with 12-20 ng of AID at 32 ˚C and 37 ˚C (Fig. 9a). We chose these temperatures because we 
previously showed that the optimal temperature for human AID is 32 ˚C (Quinlan et al., 2017). 
We used TGCbub7 as a substrate because it has been found to be AID’s most favored substrate 
amongst an extensive panel of substrates of varying structures and sequences (Larijani et al., 2007).   
Deamination kinetics analysis revealed that all versions of AID from yeast exhibited enzymatic 
activity with detectable product at 3 min at both temperatures. The product formation was 
increased to 5.8-fold for intracellular Y-AID (Fig. 9b), 3.8-fold for intracellular Y-AID-V5-His 
(Fig. 9c) and 3.3-fold for intracellular Y-GST-AID (Fig. 9d) at 60 min. The product formation was 
saturated after 60 min for all samples at 32 ˚C and 37 ˚C.  
Next we evaluated the initial deamination enzyme velocity of yeast-expressed intracellular AID 
enzymes. 12 ng equivalent of Y-GST-AID, 20 ng equivalent of Y-AID and 12 ng of Y-AID-V5-
His were incubated with the substrate (TGCbub7) concentrations ranging from 0.15 to 7.5 nM at 
32 ˚C and 37 ˚C (Fig. 10a). The velocity of product formation was determined by calculating the 
amount of product formed in a unit of time by a given amount of AID and plotted against substrate 
concentration. As shown in (Figs. 10b, c and d), the maximal activity for all AIDs was higher at 
32 ˚C than at 37 ˚C. The velocity of deamination for intracellular Y-GST-AID and Y-AID were 
almost 2.5-fold, and for Y- AID was 1.5-fold at 32 ˚C which were higher than 37 ˚C (Figs. 10b, c 
and d). Y-AID shows significantly more activity at 32 ˚C and 37 ˚C compared with Y-GST-AID 
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and Y-AID-V5-His (Figs. 10e and f). It was not possible to estimate the Km since substrate 
saturation kinetics were not observed. However, as the velocity continues to increase beyond the 
highest substrate concentration tested, the Km is likely to be higher. In conclusion, measuring the 
deamination kinetics of GST-AID, AID-V5-His and untagged AID from the yeast expression 
system revealed that the optimal temperature for maximal enzyme velocity is 32 °C which is 
consistent with AID purified from bacteria and human cell lines. Moreover, untagged AID (Y-
AID) exhibited the highest initial velocity compared with Y-GST-AID and Y-AID-His. The results 
confirmed our hypothesis that folded tags (GST) or small tags (V5-His) placed at either the N- or 
C- termini impact AID activity.  
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Figure 9. Deamination kinetics comparing the activities of intracellular Y-GST-AID, Y-AID-
V5-His and Y-AID. 25 fmol substrate was incubated with AID for various times at 32 ˚C and 37 
˚C. (a) A representative alkaline cleavage gel of product formation for 12-20 ng AID is shown as 
a function of incubation time. Comparison of activity kinetics on TGCbub7 for intracellular Y-
AID (b), intracellular Y-AID-V5-His. P values for 32 ˚C vs. 37 ˚C were > 0.05 and not significant 
for Y-AID and Y-AID-V5-His (c) and intracellular Y- GST-AID. P value for 32 ˚C vs. 37 ˚C was 
0.004 and difference was significant. (d). Error bars show s.d. from three independent experiments. 
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Figure 10. Deamination kinetics comparing the activities of Intracellular Y-GST-AID, Y-
AID-V5-His and Y-AID at 32 ˚ C and 37 ˚ C. (a) Examples of the representative deamnation assay 
gels used to measure activity of AID from yeast on serial dilutions of TGCbub7. Assay was 
performed using defined concentrations of GST-AID, AID-V5-His and untagged AID or GST-
AID and serial dilutions of the substrate starting with 0.15 nM. The product and substrate bands 
were quantified and used together with the incubation time and the amount of AID to calculate the 
reaction velocity at 32 ˚C and 37 ˚C (graph). Velocity is defined as the amount of deaminated 
product generated by a given amount of AID in a unit of time and plotted against substrate 
concentration. Deamination kinetics showing the activity of intracellular Y-AID (b), intracellular 
Y-AID-V5-His (c) and intracellular Y- GST-AID (d) from yeast on dilutions (0.15 to 7.5 nM) of 
TGCbub7 substrates at 32 ˚C and 37 ˚C. P values for all were > 0.05 and not significant.  
Deamination kinetics of Y-AID, Y-GST-AID and Y-AID-V5-His were compared each at 37 ˚C   
P value <0.0001 (e) Deamination kinetics of Y-AID, Y-GST-AID and Y-AID-V5-His were 
compared each at 32 ˚C   P value <0.0001 (f). Error bars show s.d. from three independent 
experiments. 
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Discussion 
 
AID/APOBECs are cytosine deaminase enzymes involved in boosting immune response and 
contributing to mutation in cancer. Yet, many aspects of their structure and regulation remained 
unknown. For instance, although each AID/APOBEC enzyme can mutate genome-wide, they 
exhibit varying levels of genotoxicity and seem to be targeted to different loci, and the mechanism 
of this differential regulation is as yet not understood. Over the last few decades, many studies 
have focused on finding ways to express these toxic enzymes in variety of organisms that are quite 
different from the source organism. This would minimize the potential damage of the toxic 
enzymes on the host cells during expression as well as decrease interactions with other cellular 
proteins that may hinder purification. To date the main hosts used for the production of 
recombinant AID/APOBECs proteins are bacteria, insect cells, and mammalian cells. However, 
the expression and purification performed using the systems are labour-intensive and time-
consuming (Larijani et al., 2012; Robbiani et al., 2009; Cocker et al., 2016).  
To simplify the expression, solubilisation, and purification of recombinant proteins, the addition 
of a fusion tag at either the N- or C-terminus of recombinant proteins has been a commonly-used 
strategy. Due to the aforementioned inherent difficulties with AID/APOBEC purification, these 
fusion tags serve the dual purpose of stabilizing protein folding, as well as allowing for 
purification. On the other hand, it has been reported that both N and C termini of AID and other 
APOBECs are required for specific aspects of its enzymatic function such as homodimer formation 
and cellular localization; thus any additional amino acids from a fusion tag in either C or N- 
terminal might exert an artificial influence on AID function and structure (Bransteitter et al., 2009; 
King et al., 2015 and  2017; Zahn et al., 2014 ; Mondal et al., 2016).  
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While it is possible to cleave fusion tags from the native protein during or after column purification 
and a number of studies used the cleavage of the large tags to achieve untagged A3A, AID and 
A3G (Pham et al., 2016; Chelico et al., 2006; Pham et al., 2013), the cleavage may impose 
additional time, causing lower yield and enzyme inactivation. Additionally, tag cleaving is 
performed after expression and purification which is relatively after protein folding meaning tag 
might have imposed its effects on folding specially for big tags such as GST tag. Due to the 
tendency of AID/APOBECs to aggregate (Chelico et al., 2006), this cleavage is expected to lower 
solubility. In our experience, cleavage of the GST tag from the bacterially expressed GST-AID 
results in AID aggregation and inactivation (Larijani et al., 2012). Thus, the use of expression tags 
followed by tag cleavage is not an optimal method of obtaining a truly native protein, and a much 
better approach would be to express a protein that is native from the beginning. 
Since yeast can be made to secrete the protein of interest into a medium which is relatively clean 
and devoid of other cellular debris, this approach can be used to generate untagged proteins, rather 
than necessitating the use of purification tag followed by tag removal.  
The Methylotrophic yeast, P. pastoris, has been developed as a useful host for the high level 
expression of heterologous enzymes and proteins under the AOX1 gene promoter which is tightly 
regulated by methanol. P. pastoris has some advantages over prokaryotic cells, especially in 
regards to post-transcriptional and post-translational modifications; also the P. pastoris allows 
secretion of the recombinant protein. Secreting proteins is a desirable method for production of 
especially toxic enzymes, as it has less effect on cells and requires simpler purification from the 
secreted media, rather than separating the protein from the intracellular matrix that contains a large 
number of native proteins. P. pastoris is an attractive production host as it can be cultivated cheaply 
and rapidly on simple protein free medium, unlike mammalian cell lines. Over 500 proteins, from 
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industrial to biopharmaceuticals, have been expressed in P. pastoris (Macauley-Patrick et al., 
2005).  
Despite the above-mentioned yeast advantages, the expression of heterologous proteins in P. 
pastoris, posed a number of difficulties. Expression of a protein in a yeast system could result in 
a product with slightly different posttranslational modifications compared with the native enzyme 
(Hamilton et al., 2015); however, this could also be the case when enzymes are expressed in other 
eukaryotic cells such as insect cells. Another point which has to be taken into consideration is low 
yield of secreted protein since inefficient removal of the signal peptide may result in protein 
aggregation and retention within incorrect compartments, such as the endoplasmic reticulum (Lin-
Cereghino et al., 2013; Kurjan et al., 1982). Moreover, this might initiate other processes such as 
a type of feedback mechanism called repression under secretion stress (RESS) that is activated in 
response to an impairment of protein folding and secretion (Lambertz et al., 2013). Furthermore, 
it is possible that secreted proteins are susceptible to cleavage by secreted proteases in the media, 
and it is also possible that other metabolic by-products or factors present in the media, or even the 
changing pH of the media due to natural metabolic processes can all influence the secreted protein 
(Macauley-Patrick et al., 2005). These can be mitigated by adjusting media pH, or addition of 
protease inhibitors to the media. Additionally, The AOX1 promoter which is highly regulated by 
methanol can lead to several disadvantages such as increased need of oxygen (Krainer  et al., 2011) 
or production of hydrogen peroxide (H2O2) which can become a damaging reactive oxygen species 
(Kern et al., 2007). Hydrogen peroxide is an oxidizer and can degrade secreted AID/APOBECs 
carrying Zn.  
Given their relatively small genome and eukaryotic protein translation machinery;yeast make a 
versatile eukaryotic model to probe the diverse effects of AID/APOBECs on the human the 
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genome. Previously, AID/APOBEC-expressing yeast has been used to model transcription-
dependent cytosine deamination, various aspects of genome targeting in cancer or retro-element 
transposition inhibition by AID/APOBEC proteins (Lada et al., 2015; Poltoratsky et al., 2004; 
Schumacher et al., 2005); Here we described, ) and the first expression and purification scheme of 
AID/APOBECs from yeast.;. Using deamination-specific PCR, we were able to measure the 
number of deaminations in WRC and non-WRC motifs. In contrast to our previously established 
alkaline cleavage assay, which shows a clear preference for WRC motifs, we found the 
deamination-specific PCR illustrated a broadened targeting specificity. This difference is likely 
due to the fact that the two assays are vastly different; whilst the former examines AID activity on 
a long stretch of plasmid DNA with any type of secondary structure, the latter measures AID 
activity on a well-defined bubble substrate with a single target cytidine.  
  
Conclusion 
  
In this study we demonstrated that GST-AID and AID-V5-His can be produced in yeast and will 
be as robust as those produced in mammalian cells. The secretion system will allow us to gain 
active AID/APOBEC proteins by simple concentration of the media without using purification 
tags. Also construction and expression of untagged AID/APOBECs provides a novel platform to 
study the true native molecular properties of these proteins in the absence of added fusion tags  
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Future directions 
 
This system needs to be better optimized in terms of gaining higher yields and less degraded 
proteins especially for the secretion system. To overcome protein degradation it may prove 
advantageous to use protease-deficient strains. It is also possible to decrease proteolytic 
degradation by optimizing pH and adding amino acid supplements like casamino acids to the 
culture medium.  These supplements can enhance protein stability by acting as alternative and 
competing substrates for one or more proteases, and also can repress protease induction caused by 
nitrogen limitation. We will supplement the media with a protease inhibitor cocktail to ensure we 
obstruct as much of the potential proteolysis as possible. Also, we will fully purify the untagged 
secreted AID more efficiently using Fast Protein Liquid Chromatography (FPLC), rather than 
enrichment by simple concentration of media as we presented in this thesis. Given the encouraging 
data presented in this thesis, we propose that other APOBECs can also be successfully expressed 
and purified in yeast allowing for more accurate structure:function analysis.  
 
The system can also be used to express candidate regulatory proteins in conjunction with 
AID/APOBECs and evaluate their interactions and/or effects on AID/APOBEC activity.  For 
instance, yeast was the first model to study RNA exome functions and it is now clear that the RNA 
exosome plays a role in targeting AID to CSR. However, the mechanistic details of this association, 
are not yet understood. The study of AID and molecular interactions facilitated by yeast could 
make important contributions to paving a clearer and better path towards developing drugs and 
other strategies to manipulate the activity of AID/APOBECs. 
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Below are the sequences of the integrated oligonucleotide fragments with features common to all 
pPICZnonαB and PICZαB vectors. Sequences in the red are linkers after GST tag and AID or AID 
and V5-His tag. 
 
 
1. Mother vector pPICZnonαB 
 
 
           5' end of AOX1 mRNA                                          5' AOX1 priming site                                                   
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak   EcoRI         Pml       Sfi 1    BsmB1  Asp718I Kpn1 
 
TTCGAAACGATGAGAATTCATTTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACC 
XhoI        Sac II  Not 1                       Xba 1  
TCGAGCCGCGGCGGCCGCCAGCTTTCTA 
 
 
 
 
 
 
 
 
2. GST-V5-His in pPIZCnonαB 
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            5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak   EcoRI                   GST    sequence 
 
TTCGAAACGATGAGAATTCATATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCC 
TTGTGCAACCCACTCGACTTCTTTTGGAATATCTTGAAGAAAAATATGAAGAGCAT 
TTGTATGAGCGCGATGAAGGTGATAAATGGCGAAACAAAAAGTTTGAATTGGGTTT 
GGAGTTTCCCAATCTTCCTTATTATATTGATGGTGATGTTAAATTAACACAGTCTA 
TGGCCATCATACGTTATATAGCTGACAAGCACAACATGTTGGGTGGTTGTCCAAAA 
GAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTGGATATTAGATACGGTGT 
TTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTTGATTTTCTTAGCA 
AGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAAACATATTTA 
AATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGATGTTGT 
TTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAAA 
AACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATA 
GCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAA 
 
ATCGGATCTGATCGAAGGTGCTGGGATCCCCAGGAACTCAAGGGTCAAGACA 
ATTCTGCAGATATCCAGCACAGTGGCGGCCGCTCGAGTCTAGAGGGCCCGCGGTTCGAA 
                                                             V5 epitope                                                 Polyhistidine 
region 
 
GGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGCGTACCGGTCATCATCAC 
 
                                                  Kpn1 
            EcoR I   Pml1      Sfi1       BsmB1   Asp718 Xho1   ZSacII 
71 
 
CATCACCATTGAGAATTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCG 
         *** 
Not 1        Xba 1 
GCGGCCGCCAGCTTTCTA 
 
 
          
 
 
3. Untagged AID in pPICZnonαB 
 
 
           5' end of AOX1                                                             5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak    EcoRI                 AID  ORF sequence 
 
TTCGAAACGATGAGAATTCATATGGACAGCCTCTTGATGAACCGGAGGAAGTTTCTTTACCA 
ATTCAAAAATGTCCGCTGGGCTAAGGGTCGGCGTGAGACCTACCTGTGCTACGTAGTGAAGA 
GGCGTGACAGTGCTACATCCTTTTCACTGGACTTTGGTTATCTTCGCAATAAGAACGGCTGC 
CACGTGGAATTGCTCTTCCTCCGCTACATCTCGGACTGGGACCTAGACCCTGGCCGCTGCTA 
CCGCGTCACCTGGTTCACCTCCTGGAGCCCCTGCTACGACTGTGCCCGACATGTGGCCGACT 
TTCTGCGAGGGAACCCCAACCTCAGTCTGAGGATCTTCACCGCGCGCCTCTACTTCTGTGAG 
GACCGCAAGGCTGAGCCCGAGGGGCTGCGGCGGCTGCACCGCGCCGGGGTGCAAATAGCCAT 
CATGACCTTCAAAGATTATTTTTACTGCTGGAATACTTTTGTAGAAAACCATGAAAGAACTT 
TCAAAGCCTGGGAAGGGCTGCATGAAAATTCAGTTCGTCTCTCCAGACAGCTTCGGCGCATC 
 
CTTTTGCCCCTGTATGAGGTTGATGACTTACGAGACGCATTTCGTACTTTGGGACTTTGA 
72 
 
                                       Kpn1                *** 
EcoR I  Pml 1                  Sfi 1                BsmB 1     Asp718   Xho1        Sac II     Not1  
GAATTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCGGCGGCCG 
 
      Xba1 
CCAGCTTTCTA 
 
 
 
4. AID-V5-His in pPIZCnonαB 
 
            5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak   EcoRI                   AID     sequence 
 
TTCGAAACGATGAGAATTCATATGGACAGCCTCTTGATGAACCGGAGGAAGTTTCTTTACCA 
ATTCAAAAATGTCCGCTGGGCTAAGGGTCGGCGTGAGACCTACCTGTGCTACGTAGTGAAGA 
GGCGTGACAGTGCTACATCCTTTTCACTGGACTTTGGTTATCTTCGCAATAAGAACGGCTGC 
CACGTGGAATTGCTCTTCCTCCGCTACATCTCGGACTGGGACCTAGACCCTGGCCGCTGCTA 
CCGCGTCACCTGGTTCACCTCCTGGAGCCCCTGCTACGACTGTGCCCGACATGTGGCCGACT 
TTCTGCGAGGGAACCCCAACCTCAGTCTGAGGATCTTCACCGCGCGCCTCTACTTCTGTGAG 
GACCGCAAGGCTGAGCCCGAGGGGCTGCGGCGGCTGCACCGCGCCGGGGTGCAAATAGCCAT 
CATGACCTTCAAAGATTATTTTTACTGCTGGAATACTTTTGTAGAAAACCATGAAAGAACTT 
TCAAAGCCTGGGAAGGGCTGCATGAAAATTCAGTTCGTCTCTCCAGACAGCTTCGGCGCATC 
 
CTTTTGCCCCTGTATGAGGTTGATGACTTACGAGACGCATTTCGTACTTTGGGACTTAAGGGT 
 
73 
 
CAAGACAATTCTGCAGATATCCAGCACAGTGGCGGCCGCTCGAGTCTAGAGGGCCCGCGGTT 
                                                             V5 epitope                                                 Polyhistidine 
region 
 
CGAAGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGCGTACCGGTCATCATCAC 
                                                  Kpn1 
            EcoR I   Pml1      Sfi1       BsmB1 Asp718  Xho1    SacII 
CATCACCATTGAGAATTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCG 
         *** 
Not 1        Xba 1 
GCGGCCGCCAGCTTTCTA 
 
 
 
 
 
 
 
 
 
1. Mother vector pPICZnonαB 
 
 
           5' end of AOX1 mRNA                                          5' AOX1 priming site                                                   
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak   EcoRI         Pml        Sfi 1    BsmB1  Asp718 Kpn1 
 
74 
 
TTCGAAACGATGAGAATTCATTTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACC 
Xho I        Sac II    Not 1                   Xba 1  
TCGAGCCGCGGCGGCCGCCAGCTTTCTA 
 
2. GST-V5-His in pPIZCnonαB 
 
 
            5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak   EcoRI                   GST    sequence 
 
TTCGAAACGATGAGAATTCATATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCC 
TTGTGCAACCCACTCGACTTCTTTTGGAATATCTTGAAGAAAAATATGAAGAGCAT 
TTGTATGAGCGCGATGAAGGTGATAAATGGCGAAACAAAAAGTTTGAATTGGGTTT 
GGAGTTTCCCAATCTTCCTTATTATATTGATGGTGATGTTAAATTAACACAGTCTA 
TGGCCATCATACGTTATATAGCTGACAAGCACAACATGTTGGGTGGTTGTCCAAAA 
GAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTGGATATTAGATACGGTGT 
TTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTTGATTTTCTTAGCA 
AGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAAACATATTTA 
AATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGATGTTGT 
TTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAAA 
AACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATA 
GCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAA 
 
ATCGGATCTGATCGAAGGTGCTGGGATCCCCAGGAACTCAAGGGTCAAGACA 
ATTCTGCAGATATCCAGCACAGTGGCGGCCGCTCGAGTCTAGAGGGCCCGCGGTTCGAA 
75 
 
                                                             V5 epitope                                                 Polyhistidine 
region 
 
GGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGCGTACCGGTCATCATCAC 
 
                                                  Kpn1 
            EcoR I   Pml1      Sfi1       BsmB1 Asp718I Xho1    SacII 
CATCACCATTGAGAATTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCG 
         *** 
Not 1        Xba 1 
GCGGCCGCCAGCTTTCTA 
 
 
3. Untagged AID in pPICZnonαB 
 
 
           5' end of AOX1                                                             5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak    EcoRI                 AID  ORF sequence 
 
TTCGAAACGATGAGAATTCATATGGACAGCCTCTTGATGAACCGGAGGAAGTTTCTTTACCA 
ATTCAAAAATGTCCGCTGGGCTAAGGGTCGGCGTGAGACCTACCTGTGCTACGTAGTGAAGA 
GGCGTGACAGTGCTACATCCTTTTCACTGGACTTTGGTTATCTTCGCAATAAGAACGGCTGC 
CACGTGGAATTGCTCTTCCTCCGCTACATCTCGGACTGGGACCTAGACCCTGGCCGCTGCTA 
CCGCGTCACCTGGTTCACCTCCTGGAGCCCCTGCTACGACTGTGCCCGACATGTGGCCGACT 
TTCTGCGAGGGAACCCCAACCTCAGTCTGAGGATCTTCACCGCGCGCCTCTACTTCTGTGAG 
GACCGCAAGGCTGAGCCCGAGGGGCTGCGGCGGCTGCACCGCGCCGGGGTGCAAATAGCCAT 
CATGACCTTCAAAGATTATTTTTACTGCTGGAATACTTTTGTAGAAAACCATGAAAGAACTT 
76 
 
TCAAAGCCTGGGAAGGGCTGCATGAAAATTCAGTTCGTCTCTCCAGACAGCTTCGGCGCATC 
 
CTTTTGCCCCTGTATGAGGTTGATGACTTACGAGACGCATTTCGTACTTTGGGACTTTGA 
                                       Kpn1                *** 
EcoR I  Pml 1                  Sfi 1                BsmB 1     Asp718   Xho1        Sac II     Not1  
GAATTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCGGCGGCCG 
      Xba1 
CCAGCTTTCTA 
 
 
 
 
 
4. AID-V5-His in pPIZCnonαB 
 
            5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak   EcoRI                   AID     sequence 
 
TTCGAAACGATGAGAATTCATATGGACAGCCTCTTGATGAACCGGAGGAAGTTTCTTTACCA 
ATTCAAAAATGTCCGCTGGGCTAAGGGTCGGCGTGAGACCTACCTGTGCTACGTAGTGAAGA 
GGCGTGACAGTGCTACATCCTTTTCACTGGACTTTGGTTATCTTCGCAATAAGAACGGCTGC 
CACGTGGAATTGCTCTTCCTCCGCTACATCTCGGACTGGGACCTAGACCCTGGCCGCTGCTA 
CCGCGTCACCTGGTTCACCTCCTGGAGCCCCTGCTACGACTGTGCCCGACATGTGGCCGACT 
TTCTGCGAGGGAACCCCAACCTCAGTCTGAGGATCTTCACCGCGCGCCTCTACTTCTGTGAG 
GACCGCAAGGCTGAGCCCGAGGGGCTGCGGCGGCTGCACCGCGCCGGGGTGCAAATAGCCAT 
CATGACCTTCAAAGATTATTTTTACTGCTGGAATACTTTTGTAGAAAACCATGAAAGAACTT 
77 
 
TCAAAGCCTGGGAAGGGCTGCATGAAAATTCAGTTCGTCTCTCCAGACAGCTTCGGCGCATC 
 
CTTTTGCCCCTGTATGAGGTTGATGACTTACGAGACGCATTTCGTACTTTGGGACTTAAGGGT 
 
CAAGACAATTCTGCAGATATCCAGCACAGTGGCGGCCGCTCGAGTCTAGAGGGCCCGCGGTT 
                                                             V5 epitope                                                 Polyhistidine 
region 
 
CGAAGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGCGTACCGGTCATCATCAC 
                                                  Kpn1 
            EcoR I   Pml1      Sfi1       BsmB1 Asp718  Xho1    SacII 
CATCACCATTGAGAATTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCG 
         *** 
Not 1        Xba 1 
GCGGCCGCCAGCTTTCTA 
 
 
 
 
 
 
 
 
5. Mother vector in pPIZCαB 
 
 
           5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
78 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak                   α-factor signal sequence   
          
TTCGAAACGATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATT 
 
AGCTGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCA 
 
TCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATTTTCCAACAGCACA 
 
AATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGT 
Kex2 signal cleavage      Pst1 EcoR I    Pml1     Sif1     BsmB1 
 
ATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGGAATTCACGTGGCCCAGCCGGCCGTCTCGG 
     Kpn1          Set13 signal cleavage 
Asp718        Xho1          sac II  Not 1                          Xba I 
ATCGGTACCTCGAGCCGCGGCGGCCGCCAGCTTTCTA 
 
 
6. GST-V5-His in pPIZCαB  
 
           5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak                   α-factor signal sequence   
          
TTCGAAACGATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATT 
AGCTGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCA 
TCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATTTTCCAACAGCACA 
AATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGT 
 
x
X
H 
79 
 
Kex2 signal cleavage       Pst1   EcoR I           GST sequence 
 
ATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGGAATTCATATGTCCCCTATACTAGG 
             Set13 signal cleavage 
 
TTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTTTTGGAATATCTTGA 
AGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAATGGCGAAACAA 
AAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGATGGTGATGT 
TAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAACATGTT 
GGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTGGA 
TATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGT 
TGATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCA 
TAAAACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGC 
TCTTGATGTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGT 
TTGTTTTAAAAAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAG 
CAAGTATATAGCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCA 
 
TCCTCCAAAATCGGATCTGATCGAAGGTGCTGGGATCCCCAGGAACTCGGATATCCA 
                                             V5-epitope 
 
GCACAGTGGCGGCCGCTCGAGTCTAGAGGGCCCGCGGTTCGAAGGTAAGCCTATCCC 
                                   Polyhisitidne region 
 
TAACCCTCTCCTCGGTCTCGATTCTACGCGTACCGGTCATCATCACCATCACCATTG 
                                         Kpn1           ** 
EcoRI        Pml            Sfi1  BsmB1 Asp718   Xho1      Sac II   
   
AGAATTCATTTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCGGCG 
* 
  
80 
 
Not 1                   Xba 1      
GCCGCCAGCTTTCTA 
 
 
 
 7. GST-AID in pPIZCαB  
 
           5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak                   α-factor signal sequence   
          
TTCGAAACGATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATT 
AGCTGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCA 
TCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATTTTCCAACAGCACA 
AATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGT 
Kex2 signal cleavage           Pst1 EcoR I         GST sequence 
 
ATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGGAATTCATATGTCCCCTATACTAGG 
             Set13 signal cleavage 
TTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTTTTGGAATATCTTGA 
AGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAATGGCGAAACAA 
AAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGATGGTGATGT 
TAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAACATGTT 
GGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTGGA 
TATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGT 
TGATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCA 
TAAAACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGC 
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TCTTGATGTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGT 
TTGTTTTAAAAAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAG 
CAAGTATATAGCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCA 
 
TCCTCCAAAATCGGATCTGATCGAAGGTGCTGGGATCCCCAGGAGGACACTCTGGAC 
                            AID ORF sequence 
 
ACCACTATGGACAGCCTCTTGATGAACCGGAGGAAGTTTCTTTACCAATTCAAAAATGTCCG 
CTGGGCTAAGGGTCGGCGTGAGACCTACCTGTGCTACGTAGTGAAGAGGCGTGACAGTGCTAC 
ATCCTTTTCACTGGACTTTGGTTATCTTCGCAATAAGAACGGCTGCCACGTGGAATTGCTCTT 
CCTCCGCTACATCTCGGACTGGGACCTAGACCCTGGCCGCTGCTACCGCGTCACCTGGTTCAC 
CTCCTGGAGCCCCTGCTACGACTGTGCCCGACATGTGGCCGACTTTCTGCGAGGGAACCCCAA 
CCTCAGTCTGAGGATCTTCACCGCGCGCCTCTACTTCTGTGAGGACCGCAAGGCTGAGCCCGA 
GGGGCTGCGGCGGCTGCACCGCGCCGGGGTGCAAATAGCCATCATGACCTTCAAAGATTATTT 
TTACTGCTGGAATACTTTTGTAGAAAACCATGAAAGAACTTTCAAAGCCTGGG 
AAGGGCTGCATGAAAATTCAGTTCGTCTCTCCAGACAGCTTCGGCGCATCCTT 
 
TTGCCCCTGTATGAGGTTGATGACTTACGAGACGCATTTCGTACTTTGGGACTTTGA 
                                                              ***                                                  
EcoRI        Pml            Sfi1  BsmB1 Asp718I   Xho1      Sac II   
   
 GAATTCATTTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCGGCG 
Not 1                   Xba 1      
GCCGCCAGCTTTCTA 
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8. AID-V5-His-pPIZCαB  
 
           5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak                   α-factor signal sequence   
          
TTCGAAACGATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATT 
AGCTGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCA 
TCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATTTTCCAACAGCACA 
AATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGT 
Kex2 signal cleavage          Pst1  EcoR I      AID sequence 
 
ATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGGAATTCATATGGACAGCCTCTTGA 
            Set13 signal cleavage 
TGAACCGGAGGAAGTTTCTTTACCAATTCAAAAATGTCCGCTGGGCTAAGGGT 
CGGCGTGAGACCTACCTGTGCTACGTAGTGAAGAGGCGTGACAGTGCTACATC 
CTTTTCACTGGACTTTGGTTATCTTCGCAATAAGAACGGCTGCCACGTGGAAT 
TGCTCTTCCTCCGCTACATCTCGGACTGGGACCTAGACCCTGGCCGCTGCTAC 
CGCGTCACCTGGTTCACCTCCTGGAGCCCCTGCTACGACTGTGCCCGACATGT 
GGCCGACTTTCTGCGAGGGAACCCCAACCTCAGTCTGAGGATCTTCACCGCGC 
GCCTCTACTTCTGTGAGGACCGCAAGGCTGAGCCCGAGGGGCTGCGGCGGCTG 
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CACCGCGCCGGGGTGCAAATAGCCATCATGACCTTCAAAGATTATTTTTACTG 
CTGGAATACTTTTGTAGAAAACCATGAAAGAACTTTCAAAGCCTGGGAAGGGC 
TGCATGAAAATTCAGTTCGTCTCTCCAGACAGCTTCGGCGCATCCTTTTGCCC 
 
CTGTATGAGGTTGATGACTTACGAGACGCATTTCGTACTTTGGGACTTACTCGGATATCCA 
                                             V5-epitope 
 
GCACAGTGGCGGCCGCTCGAGTCTAGAGGGCCCGCGGTTCGAAGGTAAGCCTATCCC 
                                   Polyhisiridne region 
 
TAACCCTCTCCTCGGTCTCGATTCTACGCGTACCGGTCATCATCACCATCACCATTG 
                                         Kpn1           ** 
EcoRI        Pml            Sfi1  BsmB1 Asp718   Xho1      Sac II  Not I 
   
AGAATTCATTTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCGGCG 
* 
                      Xba 1      
GCCGCCAGCTTTCTA 
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8. Untagged AID in pPIZCαB  
 
           5' end of AOX1 mRNA                                                       5' AOX1 priming site  
 
AACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGA 
 
CAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTA 
   Kozak                   α-factor signal sequence   
          
TTCGAAACGATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATT 
AGCTGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCA 
TCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATTTTCCAACAGCACA 
AATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGT 
Kex2 signal cleavage         Pst1   EcoR I     AID ORF sequence 
 
ATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGGAATTCATATGGACAGCCTCTTGA 
            Set13 signal cleavage 
TGAACCGGAGGAAGTTTCTTTACCAATTCAAAAATGTCCGCTGGGCTAAGGGT 
CGGCGTGAGACCTACCTGTGCTACGTAGTGAAGAGGCGTGACAGTGCTACATC 
CTTTTCACTGGACTTTGGTTATCTTCGCAATAAGAACGGCTGCCACGTGGAAT 
TGCTCTTCCTCCGCTACATCTCGGACTGGGACCTAGACCCTGGCCGCTGCTAC 
CGCGTCACCTGGTTCACCTCCTGGAGCCCCTGCTACGACTGTGCCCGACATGT 
GGCCGACTTTCTGCGAGGGAACCCCAACCTCAGTCTGAGGATCTTCACCGCGC 
GCCTCTACTTCTGTGAGGACCGCAAGGCTGAGCCCGAGGGGCTGCGGCGGCTG 
CACCGCGCCGGGGTGCAAATAGCCATCATGACCTTCAAAGATTATTTTTACTG 
  
85 
 
CTGGAATACTTTTGTAGAAAACCATGAAAGAACTTTCAAAGCCTGGGAAGGGC 
TGCATGAAAATTCAGTTCGTCTCTCCAGACAGCTTCGGCGCATCCTTTTGCCC 
 
CTGTATGAGGTTGATGACTTACGAGACGCATTTCGTACTTTGGGACTTTGA 
                                                       *** 
                                         Kpn1           
EcoRI        Pml            Sfi1  BsmB1 Asp718   Xho1      Sac II   
   
 GAATTCATTTCACGTGGCCCAGCCGGCCGTCTCGGATCGGTACCTCGAGCCGCGGC 
Not 1                   Xba 1      
GGCCGCCAGCTTTCTA 
 
 
 
 
 
 
 
               
 
 
               
 
 
 
 
 
 
 
 
86 
 
 
 
 
 
 
 
 
 
 
 
 
